Ligand Pharmaceuticals (LGND) Change in Intangibles (2010 - 2019)
Ligand Pharmaceuticals' (LGND) quarterly Change in Intangibles came in at $812.8 million in Q1 2019, up 635097.66% quarter-over-quarter from -$128000.0 in Q4 2010.
Ligand Pharmaceuticals (LGND) Change in Intangibles (2010 - 2019) Analysis & Trends
Ligand Pharmaceuticals has disclosed Change in Intangibles across 2 years of filings, most recently posting $812.8 million for Q1 2019.
- Change in Intangibles for Q1 2019 came in at $812.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $812.8 million (changed N/A YoY), and the FY2019 annual result was $812.8 million, changed N/A from the prior year.
- Change in Intangibles came in at $812.8 million for Q1 2019 at Ligand Pharmaceuticals, up from -$128000.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $812.8 million in Q1 2019 to a low of $812.8 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 5.47 Bn | 4.69 Bn | 48.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 812.80 Mn |
| Mar 31, 2019 | 812.80 Mn |
| Dec 31, 2010 | -128,000.00 |
| Dec 31, 2010 | -128,000.00 |